Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Feuerstein

Showing results (371-380 of 385) with videos related to

Pageof 39
Sort By:
AJNR. American Journal of Neuroradiology|December 6, 2008
Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurementsL S Hu, L C Baxter, K A Smith, et al.
Cancer Research|March 9, 2005
Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastomaJanice M Nigro, Anjan Misra, Li Zhang, et al.
Oncogene|July 20, 2007
Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signatureN Tomioka, S Oba, M Ohira, et al.
Medical and Pediatric Oncology|July 24, 2001
Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: how many genetic subgroups are there?J Vandesompele, F Speleman, N Van Roy, et al.
Cancer Cell|March 15, 2006
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesisHeidi S Phillips, Samir Kharbanda, Ruihuan Chen, et al.
Oncogene|August 6, 1999
Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtypeJ S Smith, B Alderete, Y Minn, et al.
AJNR. American Journal of Neuroradiology|November 19, 2011
Correlations between perfusion MR imaging cerebral blood volume, microvessel quantification, and clinical outcome using stereotactic analysis in recurrent high-grade gliomaL S Hu, J M Eschbacher, A C Dueck, et al.
Neuro-Oncology|May 8, 2012
Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survivalLeland S Hu, Jennifer M Eschbacher, Joseph E Heiserman, et al.
AJNR. American Journal of Neuroradiology|September 15, 2009
Optimized preload leakage-correction methods to improve the diagnostic accuracy of dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in posttreatment gliomasL S Hu, L C Baxter, D S Pinnaduwage, et al.
Journal of Neurosurgery|July 25, 2020
Provision of rapid and specific ex vivo diagnosis of central nervous system lymphoma from rodent xenograft biopsies by a fluorescent aptamerJoseph Georges, Xiaodong Qi, Xiaowei Liu, et al.
Pageof 39

Showing results (371-380 of 385) with videos related to

Sort By:
Pageof 39
AJNR. American Journal of Neuroradiology|December 6, 2008
Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurementsL S Hu, L C Baxter, K A Smith, et al.
Cancer Research|March 9, 2005
Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastomaJanice M Nigro, Anjan Misra, Li Zhang, et al.
Oncogene|July 20, 2007
Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signatureN Tomioka, S Oba, M Ohira, et al.
Medical and Pediatric Oncology|July 24, 2001
Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: how many genetic subgroups are there?J Vandesompele, F Speleman, N Van Roy, et al.
Cancer Cell|March 15, 2006
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesisHeidi S Phillips, Samir Kharbanda, Ruihuan Chen, et al.
Oncogene|August 6, 1999
Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtypeJ S Smith, B Alderete, Y Minn, et al.
AJNR. American Journal of Neuroradiology|November 19, 2011
Correlations between perfusion MR imaging cerebral blood volume, microvessel quantification, and clinical outcome using stereotactic analysis in recurrent high-grade gliomaL S Hu, J M Eschbacher, A C Dueck, et al.
Neuro-Oncology|May 8, 2012
Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survivalLeland S Hu, Jennifer M Eschbacher, Joseph E Heiserman, et al.
AJNR. American Journal of Neuroradiology|September 15, 2009
Optimized preload leakage-correction methods to improve the diagnostic accuracy of dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in posttreatment gliomasL S Hu, L C Baxter, D S Pinnaduwage, et al.
Journal of Neurosurgery|July 25, 2020
Provision of rapid and specific ex vivo diagnosis of central nervous system lymphoma from rodent xenograft biopsies by a fluorescent aptamerJoseph Georges, Xiaodong Qi, Xiaowei Liu, et al.
Pageof 39